5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb studyJ. Randolph Hecht, Albrecht Kretzschmar, Takayuki Yoshino et al.|Cancer Management and Research|2015Cited by 10